moxalactam has been researched along with flomoxef in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
| Bauernfeind, A; Eberlein, E; Jungwirth, R; Schweighart, S | 1 |
| Chimura, T; Saito, H | 1 |
| Hirauchi, K; Matsubara, T; Uchida, K | 1 |
| Heizmann, W; Luft, G; Werner, H | 1 |
| Haga, T; Miyashita, H; Muraoka, A; Nishiya, H; Nozue, N; Ono, Y; Ueda, Y | 1 |
| Harauchi, T; Hirata, M; Itoh, F; Mizushima, Y; Sato, K | 1 |
| Kariyazono, H; Moriyama, Y; Nakamura, K; Shinkawa, T; Taira, A; Toyohira, H; Yamada, K | 1 |
| Harada, K; Iyori, K; Jitsuiki, M; Kanao, Y; Kusumoto, M; Narita, H; Torii, K; Tsunoi, M; Tsuyuki, Y | 1 |
9 other study(ies) available for moxalactam and flomoxef
| Article | Year |
|---|---|
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin).
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cefozopran; Cefpirome; Cephalosporins; Drug Stability; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Tazobactam | 1991 |
[A clinical study of asymptomatic bacteriospermia].
Topics: 4-Quinolones; Anti-Infective Agents; Cephalexin; Cephalosporins; Enterococcus faecalis; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Moxalactam; Quinolones; Semen; Staphylococcus epidermidis; Streptococcus agalactiae | 1990 |
Studies on oxacephem antibiotics: comparison of the effects of 1-oxa and 1-thia cephalosporins on blood coagulation activities and vitamin K metabolism in rats.
Topics: Animals; Blood Coagulation; Cephalosporins; Factor VII; Fibrinogen; Male; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Inbred Strains; Vitamin K; Vitamin K Deficiency | 1989 |
In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; Cefotaxime; Cefoxitin; Cephalosporins; Clindamycin; Clostridium; Moxalactam; Peptococcaceae; Propionibacterium acnes | 1988 |
[Laboratory and clinical studies of flomoxef].
Topics: Adult; Bacteria; Bacterial Infections; Cefazolin; Cefmetazole; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Infusions, Intravenous; Klebsiella; Male; Middle Aged; Moxalactam | 1987 |
[Modification of vancomycin nephrotoxicity by other antibiotics in rats].
Topics: Animals; Cefpirome; Cephalosporins; Drug Therapy, Combination; Kidney; Male; Moxalactam; Rats; Rats, Sprague-Dawley; Vancomycin | 1995 |
Inhibitory effects of antibiotics on platelet aggregation in vitro.
Topics: Adult; Anti-Bacterial Agents; Blood Platelets; Cefamandole; Cephalosporins; Collagen; Female; Humans; Male; Middle Aged; Moxalactam; Platelet Aggregation Inhibitors | 1997 |
In vitro efficacy of cephamycins against multiple extended-spectrum β-lactamase-producing Klebsiella pneumoniae, Proteus mirabilis, and Enterobacter cloacae isolates from dogs and cats.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cat Diseases; Cats; Cefmetazole; Cephamycins; Dog Diseases; Dogs; Enterobacter cloacae; Enterobacteriaceae; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Proteus mirabilis | 2023 |